2008
DOI: 10.1134/s1990750808030116
|View full text |Cite
|
Sign up to set email alerts
|

Matrix metalloproteinases 2 and 9 as the factors of head and neck tumor metastases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
3
0
1

Year Published

2015
2015
2015
2015

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(4 citation statements)
references
References 12 publications
0
3
0
1
Order By: Relevance
“…The correlation between these MMPs and degree and stage of tumor and lymph node metastasis and poor prognosis are well shown. MMP-9 has shown to be better predictor of poor prognosis compared to MMP-2 (Sun et al, 2007;Kondakova et al, 2008;Gou et al, 2010;Cao et al, 2011;Mallis et al, 2012;Colovic et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…The correlation between these MMPs and degree and stage of tumor and lymph node metastasis and poor prognosis are well shown. MMP-9 has shown to be better predictor of poor prognosis compared to MMP-2 (Sun et al, 2007;Kondakova et al, 2008;Gou et al, 2010;Cao et al, 2011;Mallis et al, 2012;Colovic et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Alireza Lotfi 1 , Ghodrat Mohammadi 1 , Atena Tavassoli 2 *, Mehrnoosh mousaviagdas 1 , Hadi Chavoshi 2 , Lale Saniee 2 1999); however, MMP-9 compared to MMP-2 has shown to be more related to distant metastasis, lymph node involvement and higher stage of the disease (Katayama et al, 2004;de Vicente et al, 2005;Kondakova et al, 2008;Singh et al, 2010;Monteiro-Amado et al, 2013;Vilen et al, 2013;Bedal et al, 2014).…”
Section: Serum Levels Of Mmp9 and Mmp2 In Patients With Oral Squamous Cell Carcinomamentioning
confidence: 99%
“…However, the studies in this regard have usually measured histologic expression of MMPs and not their serum levels (Katayama et al, 2004;de Vicente et al, 2005;Kondakova et al, 2008;Singh et al, 2010;Monteiro-Amado et al, 2013;Vilen et al, 2013;Bedal et al, 2014). There are few studies evaluated different MMPs role in oral SCC in Iran (Elahi et al, 2012;Tadbir et al, 2012;Mohtasham et al, 2013).…”
Section: Serum Levels Of Mmp9 and Mmp2 In Patients With Oral Squamous Cell Carcinomamentioning
confidence: 99%
“…Οι Kondakova και συν. διαπίστωσαν σχέση μεταξύ επιπέδων MMP-9 και TIMP-1 και ανάπτυξης SCC κεφαλής και τραχήλου καθώς και μεταξύ επιπέδων της TIMP-1 του ορού και των ιστών με τη Ν1 τραχηλική μεταστατική νόσο (Kondakova et al 2008). Σε πρόσφατη μελέτη τους οι Huang και συν.…”
Section: α42 Mmps στον καρκινο κεφαλης και τραχηλουunclassified